openPR Logo
Press release

Neurovascular Devices Market is Expected to Reach USD 3.60 Billion By 2028 at a CAGR of 5.6% | Reports and Data

09-16-2022 10:13 AM CET | Health & Medicine

Press release from: Reports and Data

The Neurovascular Devices Market is forecasted to grow from USD 2.35 Billion in 2020 to USD 3.60 Billion by 2026, at a CAGR of 5.6%, during the forecast period. The market is primarily driven by the growing target population for patients, favorable medical reimbursements, expansion of healthcare infrastructure across emerging markets, and increased market demand for effective neurovascular devices.

Technological advances have increased life expectancy, resulting in an increase in geriatric population as a consequence. The geriatric population (age 60 & above) is projected to increase by 57% from 902 million in 2015 to 1.41 Billion by 2030, according to a report published by the United Nations. As a result, the aging population around the globe is expected to rise to boost demand for neurovascular devices.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/1348

Neurovascular therapy technological developments, such as the development of GORE TIGRIS by W L Gore and Medtronic distal filter embolic protection device SpiderFX, are expected to serve as a high impact rendering driver. It is expected that inclination for minimally invasive surgery in brain aneurysm and stroke treatments will be the key factor that will increase market growth.

Increasing numbers of neurovascular therapy research, increased demand for minimally invasive neurochirurgical procedures, and increased awareness for minimally invasive surgical procedures among neurochirurgists provide significant market growth opportunities. However, strict regulatory scenario and skilled neurosurgeon dearth may hinder the growth of the market during the forecast period.

Further key findings from the report suggest:

The Neurovascular Devices Market is forecasted to grow from USD 2.35 Billion in 2020 to USD 3.60 Billion by 2026, at a CAGR of 5.6%, during the forecast period. The market is primarily driven by the growing target population for patients, favorable medical reimbursements, expansion of healthcare infrastructure across emerging markets, and increased market demand for effective neurovascular devices.

The market for cerebral embolization and aneurysm coiling devices is expected to grow the largest at USD 1.11 Billion in 2026, at a CAGR of 6.5% during the forecast period. Growing geriatric population and cerebrovascular disorder prevalence are likely to encourage segment development. Cerebral angiography involves using contrast colors and X-rays to monitor blood flow through the brain. Products for neurothrombectomy are used in patients who are ineligible for activator therapy for tissue plasminogen.

The market for stroke is expected to grow the largest at USD 1.91 Billion in 2026, at a CAGR of 6.1% during the forecast period. Motor impairment, which causes movement disabilities, is the most common outcome associated with stroke. The primary focus in stroke rehabilitation with the help of stents and embolization coils is the recovery of lost artery functions.

In 2020, North America dominated the market for Neurovascular devices. The market for North America is expected to reach USD 1.21 Billion in 2026, at a CAGR of 6% during the forecast period. Key factors driving this growth include a favorable reimbursement structure, particularly in the U.S., large-scale R&D investments, and wide use of neurochirurgical products supported by the availability of advanced technologies with higher efficiency and confidence.

Competitive Landscape:

The report also focuses on details of each market player including its global position, financial standing, revenue generation, company overview, and product & service portfolio. The Neurovascular Devices market is extremely competitive and consists of several key players at the regional and global levels. Key players are focused on adopting various strategies such as new product launches, mergers and acquisitions, investments in R&D, partnerships, joint ventures, and collaborations to strengthen their market position and enhance their product portfolio.

Leading companies operating in the market are:

W. L. Gore & Associates, Inc. (US), Terumo Corp. (Japan), Abbott Laboratories (US), Merit Medical Systems, Inc. (US), Medtronic Plc (Ireland), Penumbra, Inc. (US), Stryker Corp. (US), Johnson & Johnson (US), MicroPort Scientific Corp. (China) and others.

Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/1348

The report also offers detailed insights about market segmentation based on type, application and regional bifurcation:

Neurovascular Devices Market Segmentation:

Type (Revenue, USD Million; 2018-2028)

Cerebral Embolization and Aneurysm Coiling
Embolic Coils
Flow Diversion
Liquid Embolic Agents
Cerebral Angioplasty and Stenting Systems
Carotid Artery Stents
Embolic Protection Systems
Neurothrombectomy
Clot Retrieval
Suction
Vascular Snares
Support
Micro Catheters
Micro Guidewires

Application (Revenue, USD Million; 2018-2028)

Cerebral Artery Stenosis
Stroke
Cerebral Aneurysm
Others

Regional Outlook:

North America (U.S., Canada, Mexico)
Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
Latin America (Brazil, Rest of LATAM)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of the Middle East & Africa)

Some essential purposes of the Neurovascular Devices market research report:

Vital Developments: Custom investigation provides critical improvements to the Neurovascular Devices market, including R&D, new item shipment, coordinated efforts, development rate, partnerships, joint efforts, and local development of rivals working in the market on a global scale and regional.

Market Characteristics: The report contains Neurovascular Devices market highlights, income, limit, limit utilization rate, value, net, creation rate, generation, utilization, import, trade, supply, demand, cost, part of the industry in general, CAGR, and gross margin. Likewise, the market report offers an exhaustive investigation of the elements and their most recent patterns, along with Service market fragments and subsections.

Investigative Tools: This market report incorporates the accurately considered and evaluated information of the major established players and their extension into the Neurovascular Devices market by methods. Systematic tools and methodologies, for example, Porter's Five Powers Investigation, Possibilities Study, and numerous other statistical investigation methods have been used to analyze the development of the key players working in the Neurovascular Devices market.

Convincingly, the Neurovascular Devices report will give you an unmistakable perspective on every single market reality without the need to allude to some other research report or source of information. This report will provide all of you with the realities about the past, present, and eventual fate of the Neurovascular Devices market.

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/1348

Thank you for reading the report. Kindly note that we also offer customized reports according to the client's requirements. Contact us to know more about the customization feature and our team will provide you with the best-customized report.

Explore More Industry Research by Reports and Data:

Behcets Disease Market @ https://www.biospace.com/article/increasing-prevalence-of-rare-and-genetic-disease-is-expected-to-drive-behcets-disease-market-revenue-growth-by-2030/

Hemiplegia Market @ https://www.biospace.com/article/increasing-neural-disorders-and-stroke-is-expected-to-drive-hemiplegia-market-growth-by-2030/

Autoimmune Hepatitis Market @ https://www.biospace.com/article/incidence-of-viral-disease-is-expected-to-drive-autoimmune-hepatitis-market-revenue-growth-by-2030/

Contact Us:

John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neurovascular Devices Market is Expected to Reach USD 3.60 Billion By 2028 at a CAGR of 5.6% | Reports and Data here

News-ID: 2737382 • Views:

More Releases from Reports and Data

U.S. Electric Vehicle Charging Infrastructure Market Surges Toward $56.73 Billion by 2034, Transforming National Transportation
U.S. Electric Vehicle Charging Infrastructure Market Surges Toward $56.73 Billio …
The U.S. Electric Vehicle (EV) Charging Infrastructure Market reached a value of USD 5.48 billion in 2024 and is projected to surge to USD 56.73 billion by 2034, fueled by a robust CAGR of 26.1% over the period. This unprecedented growth underscores the sector's central role in decarbonizing transportation and meeting the soaring demands of electric mobility. Market Drivers Federal & State Policies: Major initiatives, including the Bipartisan Infrastructure Law and significant
Automotive Refurbished Turbochargers Market to Reach USD 1.7 Billion by 2034, Driven by Sustainability and Cost Efficiency
Automotive Refurbished Turbochargers Market to Reach USD 1.7 Billion by 2034, Dr …
The global Automotive Refurbished Turbochargers Market is set to grow from USD 0.9 billion in 2024 to USD 1.7 billion by 2034, recording a steady compound annual growth rate (CAGR) of 6.00%. This growth is being propelled by rising demand for affordable, fuel-efficient automotive solutions and stricter environmental regulations pushing the need for emission-reducing technologies. Get Free Sample Report and Related Graphs & Charts @https://www.reportsanddata.com/sample-enquiry-form/19490 Passenger vehicles remain the largest segment of
Automotive Powertrain Cooling System Market to Reach USD 8.2 Billion by 2034, Driven by EV Boom and Emission Standards
Automotive Powertrain Cooling System Market to Reach USD 8.2 Billion by 2034, Dr …
The global Automotive Powertrain Cooling System Market is projected to grow from USD 4.3 billion in 2024 to USD 8.2 billion by 2034, at a CAGR of 6.60%, according to the latest market study. This growth is fueled by the rising demand for fuel-efficient vehicles, increasing electric vehicle (EV) sales, and stricter global emission regulations. Request a Sample Report with Table of Contents and Figures to click Here: @ https://www.reportsanddata.com/sample-enquiry-form/19489 Electric and
Automotive Inverter Market to Reach USD 16.9 Billion by 2034 Driven by EV Growth
Automotive Inverter Market to Reach USD 16.9 Billion by 2034 Driven by EV Growth
The global Automotive Inverter Market is on track for strong expansion, with forecasts projecting it will rise from USD 4.8 billion in 2024 to USD 16.9 billion by 2034, marking a compound annual growth rate (CAGR) of 13.2%. This rapid growth is being propelled by the increasing adoption of electric and hybrid vehicles, along with continued innovation in inverter technologies. Electric vehicles (EVs) are the main driver behind this surge, as

All 5 Releases


More Releases for Neurovascular

Emerging Trends Influencing The Growth Of The Neurovascular Catheters Market:Inn …
The Neurovascular Catheters Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. How Big Is the Neurovascular Catheters Market Size Expected to Be by 2034? The Neurovascular Catheters Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034.
Top Factor Driving Neurovascular Embolization Devices Market Growth in 2025: Ris …
What combination of drivers is leading to accelerated growth in the neurovascular embolization devices market? The rise in the prevalence of hemorrhages is expected to drive the neurovascular embolization devices market. Hemorrhages, caused by factors such as hypertension and anticoagulant medications, are treated using neurovascular embolization devices, which block abnormal blood vessels to reduce bleeding and prevent further brain damage. In February 2024, research by King's College London indicated a projected
Exploring the Neurovascular Catheters Market: Innovative Approaches to Neurovasc …
Allied Market Research Analyst have added a new research study on Title Neurovascular Catheters Market, Global Outlook and Forecast 2023-2030 with detailed information & Key Players Such as Zeus Industrial Products, Stryker, Biomerics, Integra Life Sciences, Concentric Medical, DePuy Synthes, Medtronic, RAUMEDIC, Johnson and Johnson, Integer Holdings Corporation. The Study provides in-depth comprehensive analysis includes Clear Market definitions, classifications, manufacturing processes, cost structures, development policies and plans. The facts and
Neurovascular Devices industry expected to hit a valuation of US$ 7 billion till …
The global 𝐍𝐞𝐮𝐫𝐨𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 market is estimated to attain a valuation of US$ 7 Bn by the end of 2033, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 7.6% during the forecast period, 2023 - 2033. The key objective of the TMR report is to offer a complete assessment of the global market including major leading
Brain Aneurysm Treatment - Modern Neurovascular Techniques
Brain aneurysm is a development of bulge in brain vessels. This bulging puts pressure on the nerves or brain tissues. This bulge may rupture or burse and can cause brain hemorrhage, which can cause death of the patient. Get PDF Brochure of Research Study @ https://bit.ly/2zir2hL Certain factors such as genetic conditions, arteriovenous malformations, untreated high blood pressure, and smoking are responsible to cause brain aneurysm. The global brain aneurysm treatment market
Neurovascular Devices Market: Opportunities and Challenges
The Neurovascular Devices Market is expected to reach USD 2.62 billion by 2021 from USD 1.74 billion in 2016, at a CAGR of 8.6% from 2016 to 2021. Increasing research activities in the field of neurovascular therapies Neurovascular devices are witnessing a growing demand among the major stakeholders globally, due to increasing clinical research activities in the field of neurovascular therapies, which offer credible clinical data related to their safety & efficacy